Materials • Major Chemicals
$25.68 ▼ -0.40
(-1.53%)
MKT CAP: $930.1M • VOL: 225.1K
52W L $13 52W H $40
FTK // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $237.3M | $187.0M | $188.1M |
| YoY Revenue Growth % | +26.9% | -0.5% | — |
| Gross Profit | $59.8M | $39.4M | — |
| Gross Margin % | 25.2% | 21.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $23.2M | $12.2M | $23.2M |
| Operating Margin % | 9.8% | 6.5% | 12.3% |
| Net Income (GAAP) | $30.5M | $10.5M | $24.7M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.2M | $3.4M | -$11.3M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $7.2M | $3.4M | -$11.3M |
| FCF Margin % | 3.0% | 1.8% | -6.0% |
| Return on Invested Capital (ROIC %) | 17.1% | 8.8% | — |
| Cash & Short-Term Equivalents | $5.7M | $4.4M | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $113.1M | $113.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FTK.